Total Debt
$787.6M
Net Debt
-$1.65B
CRISPR Therapeutics AG currently has $787.6M in total debt. Net debt is -$1.65B after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
CRSP • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.79 | 2.44 | -1.65Net Cash | 2.73 | 28.9% |
| 2025-12-31 | 0.39 | 1.98 | -1.58Net Cash | 2.27 | 17.4% |
| 2025-09-30 | 0.40 | 1.92 | -1.51Net Cash | 2.25 | 18.0% |
| 2025-06-30 | 0.22 | 1.72 | -1.51Net Cash | 2.03 | 10.6% |
| 2025-03-31 | 0.22 | 1.86 | -1.64Net Cash | 2.17 | 10.1% |
| 2024-12-31 | 0.22 | 1.90 | -1.68Net Cash | 2.24 | 10.0% |
| 2024-09-30 | 0.23 | 1.94 | -1.71Net Cash | 2.26 | 10.1% |
| 2024-06-30 | 0.23 | 2.00 | -1.77Net Cash | 2.34 | 9.9% |
| 2024-03-31 | 0.23 | 2.11 | -1.87Net Cash | 2.44 | 9.6% |
| 2023-12-31 | 0.24 | 1.69 | -1.46Net Cash | 2.23 | 10.7% |
| 2023-09-30 | 0.24 | 1.74 | -1.50Net Cash | 2.09 | 11.6% |
| 2023-06-30 | 0.25 | 1.77 | -1.52Net Cash | 2.20 | 11.2% |
| 2023-03-31 | 0.24 | 1.88 | -1.64Net Cash | 2.24 | 10.7% |
| 2022-12-31 | 0.24 | 1.82 | -1.57Net Cash | 2.24 | 10.9% |
| 2022-09-30 | 0.24 | 1.90 | -1.65Net Cash | 2.35 | 10.3% |
| 2022-06-30 | 0.24 | 2.07 | -1.82Net Cash | 2.46 | 9.8% |
| 2022-03-31 | 0.24 | 2.22 | -1.98Net Cash | 2.61 | 9.2% |
| 2021-12-31 | 0.23 | 2.38 | -2.15Net Cash | 2.75 | 8.2% |
| 2021-09-30 | 0.21 | 2.48 | -2.27Net Cash | 2.82 | 7.3% |
| 2021-06-30 | 0.19 | 2.59 | -2.40Net Cash | 2.90 | 6.6% |
| 2021-03-31 | 0.06 | 1.81 | -1.74Net Cash | 1.96 | 3.1% |
| 2020-12-31 | 0.06 | 1.69 | -1.63Net Cash | 1.83 | 3.4% |
| 2020-09-30 | 0.05 | 1.37 | -1.32Net Cash | 1.49 | 3.3% |
| 2020-06-30 | 0.05 | 0.95 | -0.89Net Cash | 1.05 | 4.8% |
| 2020-03-31 | 0.05 | 0.89 | -0.84Net Cash | 1.01 | 5.1% |
| 2019-12-31 | 0.05 | 0.94 | -0.89Net Cash | 1.07 | 4.9% |
| 2019-09-30 | 0.04 | 0.63 | -0.59Net Cash | 0.72 | 5.8% |
| 2019-06-30 | 0.04 | 0.43 | -0.39Net Cash | 0.49 | 8.5% |
| 2019-03-31 | 0.04 | 0.44 | -0.40Net Cash | 0.50 | 7.4% |
| 2018-12-31 | 0.00 | 0.46 | -0.46Net Cash | 0.49 | 0.0% |
| 2018-09-30 | 0.00 | 0.49 | -0.49Net Cash | 0.52 | 0.0% |
| 2018-06-30 | 0.00 | 0.32 | -0.32Net Cash | 0.35 | 0.0% |
| 2018-03-31 | 0.00 | 0.34 | -0.34Net Cash | 0.37 | 0.0% |
| 2017-12-31 | 0.00 | 0.24 | -0.24Net Cash | 0.27 | 0.0% |
| 2017-09-30 | 0.00 | 0.25 | -0.25Net Cash | 0.28 | 0.0% |
| 2017-06-30 | 0.00 | 0.27 | -0.27Net Cash | 0.30 | 0.0% |
| 2017-03-31 | 0.00 | 0.29 | -0.29Net Cash | 0.32 | 0.0% |
| 2016-12-31 | 0.00 | 0.32 | -0.32Net Cash | 0.34 | 0.0% |
| 2016-09-30 | 0.00 | 0.23 | -0.23Net Cash | 0.28 | 0.0% |
| 2016-06-30 | 0.00 | 0.25 | -0.25Net Cash | 0.29 | 0.0% |
| 2016-03-31 | 0.00 | 0.20 | -0.20Net Cash | 0.24 | 0.0% |
| 2015-12-31 | 0.04 | 0.16 | -0.12Net Cash | 0.16 | 24.0% |